Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
47.67
-2.94 (-5.81%)
At close: Sep 25, 2025, 4:00 PM EDT
48.00
+0.33 (0.69%)
After-hours: Sep 25, 2025, 7:37 PM EDT
Haemonetics Market Cap
Haemonetics has a market cap or net worth of $2.30 billion as of September 25, 2025. Its market cap has decreased by -38.30% in one year.
Market Cap
2.30B
Enterprise Value
3.23B
1-Year Change
-38.30%
Ranking
Category
Stock Price
$47.67
Market Cap Chart
Since December 1, 1998, Haemonetics's market cap has increased from $605.00M to $2.30B, an increase of 279.60%. That is a compound annual growth rate of 5.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 24, 2025 | 2.44B | -37.82% |
Dec 31, 2024 | 3.92B | -9.62% |
Dec 29, 2023 | 4.34B | 9.01% |
Dec 30, 2022 | 3.98B | 46.84% |
Dec 31, 2021 | 2.71B | -55.05% |
Dec 31, 2020 | 6.03B | 3.54% |
Dec 31, 2019 | 5.82B | 12.62% |
Dec 31, 2018 | 5.17B | 68.56% |
Dec 29, 2017 | 3.07B | 47.73% |
Dec 30, 2016 | 2.08B | 26.98% |
Dec 31, 2015 | 1.64B | -14.87% |
Dec 31, 2014 | 1.92B | -11.51% |
Dec 31, 2013 | 2.17B | 3.06% |
Dec 31, 2012 | 2.11B | 37.73% |
Dec 30, 2011 | 1.53B | -2.18% |
Dec 31, 2010 | 1.56B | 10.69% |
Dec 31, 2009 | 1.41B | -1.15% |
Dec 31, 2008 | 1.43B | -10.77% |
Dec 31, 2007 | 1.60B | 32.14% |
Dec 29, 2006 | 1.21B | -6.31% |
Dec 30, 2005 | 1.29B | 40.58% |
Dec 31, 2004 | 920.10M | 59.08% |
Dec 31, 2003 | 578.40M | 10.51% |
Dec 31, 2002 | 523.40M | -41.55% |
Dec 31, 2001 | 895.40M | 15.08% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 669.64B |
Johnson & Johnson | 424.93B |
AbbVie | 394.07B |
UnitedHealth Group | 317.35B |
Novo Nordisk | 268.59B |
AstraZeneca | 240.79B |
Novartis AG | 239.81B |
Abbott Laboratories | 235.59B |